Thromboangiitis Obliterans [PDF]
Anatolian Journal of Cardiology, 2021 Ju yi Chen
doaj +5 more sources
Thromboangiitis obliterans (Buerger's disease) - a review [PDF]
Journal of Education, Health and Sport, 2023 Introduction: Thromboangiitis obliterans (Buerger's disease) is a segmental, multilocular, nonatherosclerotic inflammatory disease that most commonly affects small and medium sized arteries, veins and nerves of the extremities.
Rafał Bogacz +6 more
doaj +3 more sources
The Incidence and Prevalence of Thromboangiitis Obliterans in Taiwan: A Nationwide, Population-based Analysis of Data Collected from 2002 to 2011 [PDF]
Clinics, 2016 OBJECTIVE: To estimate the incidence and prevalence of thromboangiitis obliterans in Taiwan in the period spanning from 2002 to 2011. METHODS: We identified all incident and prevalent cases with a diagnosis of thromboangiitis obliterans (International ...
Jie-Fu Zheng +4 more
doaj +4 more sources
Thromboangiitis obliterans (Buerger's disease) [PDF]
Orphanet Journal of Rare Diseases, 2006 Thromboangiitis obliterans or Buerger's disease is a segmental occlusive inflammatory condition of arteries and veins, characterized by thrombosis and recanalization of the affected vessels.
Arkkila Perttu ET
doaj +2 more sources
Treatment of thromboangiitis obliterans (Buerger's disease) with bosentan [PDF]
BMC Cardiovascular Disorders, 2012 Background This study assessed the effectiveness and safety of bosentan when administered to thromboangiitis obliterans (Buerger's disease) patients.
De Haro Joaquin +4 more
doaj +3 more sources
Therapeutic Effect and Mechanism of Si-Miao-Yong-An-Tang on Thromboangiitis Obliterans Based on the Urine Metabolomics Approach [PDF]
Frontiers in Pharmacology, 2022 Si-Miao-Yong-An-Tang (SMYAT) is a classic prescription for the treatment of thromboangiitis obliterans (TAO). However, the effect and mechanism are still unclear.
Hui-Yu Li +10 more
doaj +2 more sources
Journal of the American Heart Association, 2018 Background Data regarding long‐term outcome of patients with thromboangiitis obliterans are lacking and most series come from India and Japan. In this study, we assess long‐term outcome and prognostic factors in a large cohort of thromboangiitis ...
Alexandre Le Joncour +2 more
exaly +3 more sources
Intestinal thromboangiitis obliterans: a case report [PDF]
Journal of Medical Case Reports, 2021 Background Thromboangiitis obliterans or Buerger’s disease is a form of peripheral vascular disease in young male smokers. The involvement of the intestine occurs in only about 2% of the cases, when they may present as acute abdomen due to mesenteric ...
Swastik Sourav Mishra +3 more
doaj +2 more sources
An improved bone transport surgical method for treating chronic ischemic ulcers (thromboangiitis obliterans) [PDF]
Frontiers in Surgery, 2022 IntroductionThe chronic ischemic injury of the upper/lower limbs caused by thromboangiitis obliterans (TAO, Buerger's disease) is difficult to heal, leading to high morbidity and amputation risk, seriously lowering the quality of life of patients. So far,
Liang Zhao +4 more
doaj +2 more sources
Endothelial activation in thromboangiitis obliterans: mechanisms and therapeutic horizons [PDF]
Frontiers in ImmunologyThromboangiitis obliterans (TAO) is a non-atherosclerotic, inflammatory vasculopathy characterized by thrombotic occlusion of small- and medium-sized vessels, leading to tissue ischemia and gangrene.
Wanting Wang, Siyao Chang, Gang Zhao
doaj +2 more sources